ABT vs. ISRG, BSX, SYK, MDT, BDX, EW, IDXX, RMD, DXCM, and STE
Should you be buying Abbott Laboratories stock or one of its competitors? The main competitors of Abbott Laboratories include Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Abbott Laboratories vs.
Intuitive Surgical (NASDAQ:ISRG) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, analyst recommendations, earnings and institutional ownership.
83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 0.7% of Intuitive Surgical shares are owned by insiders. Comparatively, 0.5% of Abbott Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Intuitive Surgical had 12 more articles in the media than Abbott Laboratories. MarketBeat recorded 53 mentions for Intuitive Surgical and 41 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.36 beat Intuitive Surgical's score of 1.34 indicating that Abbott Laboratories is being referred to more favorably in the news media.
Abbott Laboratories has a net margin of 31.95% compared to Intuitive Surgical's net margin of 27.81%. Abbott Laboratories' return on equity of 20.74% beat Intuitive Surgical's return on equity.
Intuitive Surgical currently has a consensus target price of $611.86, suggesting a potential upside of 24.84%. Abbott Laboratories has a consensus target price of $137.94, suggesting a potential upside of 7.95%. Given Intuitive Surgical's higher probable upside, equities research analysts plainly believe Intuitive Surgical is more favorable than Abbott Laboratories.
Intuitive Surgical has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500.
Intuitive Surgical received 107 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 69.97% of users gave Abbott Laboratories an outperform vote while only 68.87% of users gave Intuitive Surgical an outperform vote.
Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Summary
Intuitive Surgical beats Abbott Laboratories on 10 of the 19 factors compared between the two stocks.
Get Abbott Laboratories News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Abbott Laboratories Competitors List
Related Companies and Tools
This page (NYSE:ABT) was last updated on 4/15/2025 by MarketBeat.com Staff
Buy ABT Stock Free ABT Stock Alerts